Updated Results From the Momentum Phase 3 Study of Momelotinib vs. Danazol in Symptomatic and Anemic MF Pts Previously Treated With a JAK Inhibitor

218 views
December 16, 2022
0 Comments
Login to view comments. Click here to Login